Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × acalabrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Non-Hodgkin 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Biopsy 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Sirolimus 1 Pharmacogenomic Variants 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡